← Comparing 2 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
eIF2α Phosphorylation Imbalance Disrupts Mitochondrial Prote (EIF2S1,eIF2α,PERK,GCN2,ATF4,TOMM20,TIMM23,NDUFS1,NDUFS3,COX4I1,COX5A,mitochondrial protein import) — 0.00 Closed-loop transcranial focused ultrasound to restore hippo (SST) — 0.00 LDLR-Primed LRP1 Transcytosis with pH-Responsive Escape Stra (LDLR) — 0.00 GLUT1-Mediated Carrier-Conjugate Delivery Strategy (LDLR) — 0.00 TBK1 Loss Triggers Astrocyte-to-Neuron Senescence Propagatio (TBK1 → NF-κB / IRF3 / p62-autophagy / SASP effectors) — 0.00 LDLR-Mediated Neurosteroid Precursor Delivery Strategy (LDLR) — 0.00 Alpha-theta entrainment therapy to enhance default mode netw (SST) — 0.00 LAMP2A Upregulation to Enhance Chaperone-Mediated Autophagy (LAMP2A) — 0.00 TBK1 Loss Triggers eIF2α-Mediated Translational Repression T (TBK1, EIF2S1) — 0.00 LAMP1 Overexpression to Enhance Lysosomal Capacity Independe (LAMP1) — 0.00 Cell-Type-Specific TFEB Modulation Combined with Trehalose f (TFEB) — 0.00 Closed-loop transcranial focused ultrasound with gamma entra (PVALB) — 0.00 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.97 GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl (GRIN2B) — 0.96 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.96 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.96 Cortico-Striatal Synchrony Restoration via NMDA Modulation (GRIN2B) — 0.95 Gamma entrainment therapy to restore hippocampal-cortical sy (SST) — 0.95 Plasma NfL Elevation Secondary to BBB-Associated Transport D (NEFL) — 0.94 Microglial-Mediated Tau Clearance Dysfunction via TREM2 Rece (MAPT) — 0.94 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming (NLRP3, CASP1, IL1B, PYCARD) — 0.92 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 eIF2α Phosphorylation Imbalance Creates Integrated Stress Re (EIF2S1,eIF2α,PERK,GCN2,ATF4,ATF5,CHOP,DDIT3,integrated stress response,protein synthesis) — 0.90 APOE-Dependent Autophagy Restoration (MTOR) — 0.89 Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Colla (SLC16A1, SLC16A7, LDHA, PDHA1) — 0.89 p38α Inhibitor and PRMT1 Activator Combination to Restore Ph (MAPK14/PRMT1) — 0.89 SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc (SIRT1) — 0.89 TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener (TREM2) — 0.89 ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro (ACSL4) — 0.89 Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa (APP/PSEN1 (Aβ production), CHAT (cholinergic synthesis)) — 0.89
Add
|
× Complement C1QA Inhibitio × TREM2 Activation as an Am
C1QA, PVALB · neurodegeneration · combination
Composite 0.659
Price $0.54
Evidence For 0
Evidence Against 0
## Mechanistic Overview
Complement C1QA Inhibition Synergizes with PV Interneuron Modulation starts from the claim that modulating C1QA, PVALB within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview Complement C1QA Inhibition Synergizes with PV Interneuron Modulation starts from the claim that modulating C1QA, PVALB within the disease context of neurodegeneration can redirect a disease-relevant process. The
TREM2 · neurodegeneration · combination
Composite 0.657
Price $0.56
Evidence For 0
Evidence Against 0
## Mechanistic Overview
TREM2 Activation as an Amplification Node for R136S Protection starts from the claim that modulating TREM2 within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview TREM2 Activation as an Amplification Node for R136S Protection starts from the claim that modulating TREM2 within the disease context of neurodegeneration can redirect a disease-relevant process. The original description re
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
Neuroinflammation Synaptic Circuit Dysfunction neurodegeneration
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary 4/11
dimensions won
Complement C1QA Inhibition Synergizes wi
7/11
dimensions won
TREM2 Activation as an Amplification Nod
Radar Chart — 10 Dimensions
Score Breakdown
Dimension Complement C1QA Inhibition Syn TREM2 Activation as an Amplifi Mechanistic 0.480 0.550 Evidence 0.450 0.500 Novelty 0.550 0.450 Feasibility 0.420 0.550 Impact 0.580 0.600 Druggability 0.500 0.580 Safety 0.520 0.420 Competition 0.550 0.480 Data 0.480 0.520 Reproducible 0.520 0.500 KG Connect 0.199 0.911
Evidence Complement C1QA Inhibition Synergizes with PV Interneuron Mo No evidence citations yet
TREM2 Activation as an Amplification Node for R136S Protecti No evidence citations yet
Debate Excerpts Complement C1QA Inhibition Synergizes with PV Inte 4 rounds · quality: 0.81
Persona-Theorist
# Mechanistically Novel Hypotheses for APOE-R136S Gene Dosage Effect
## Hypothesis 1: Threshold-Dependent ABCA1-Mediated Lipid Efflux
**Title:** Lipidation Threshold Drives R136S Gene Dosage
**Me...
Persona-Skeptic # Skeptic Review: Gene Dosage Mechanisms for APOE-R136S Protection
## Hypothesis 1: Threshold-Dependent ABCA1-Mediated Lipid Efflux
### Strongest Weakness
The "therapeutic threshold" is unspecified ...
Persona-Domain Expert
# Domain Expert Assessment: APOE-R136S Gene Dosage Mechanism
## 1. Highest Translational Potential Hypotheses
### Hypothesis A: APOE Proteolytic Cleavage and Neurotoxic Fragment Reduction
**Mecha...
Persona-Synthesizer
```json
{
"ranked_hypotheses": [
{
"rank": 1,
"title": "APOE Proteolytic Cleavage Suppression and Toxic N-terminal Fragment Reduction",
"mechanism": "R136S stabilizes native ...
TREM2 Activation as an Amplification Node for R136 4 rounds · quality: 0.81
Persona-Theorist
# Mechanistically Novel Hypotheses for APOE-R136S Gene Dosage Effect
## Hypothesis 1: Threshold-Dependent ABCA1-Mediated Lipid Efflux
**Title:** Lipidation Threshold Drives R136S Gene Dosage
**Me...
Persona-Skeptic # Skeptic Review: Gene Dosage Mechanisms for APOE-R136S Protection
## Hypothesis 1: Threshold-Dependent ABCA1-Mediated Lipid Efflux
### Strongest Weakness
The "therapeutic threshold" is unspecified ...
Persona-Domain Expert
# Domain Expert Assessment: APOE-R136S Gene Dosage Mechanism
## 1. Highest Translational Potential Hypotheses
### Hypothesis A: APOE Proteolytic Cleavage and Neurotoxic Fragment Reduction
**Mecha...
Persona-Synthesizer
```json
{
"ranked_hypotheses": [
{
"rank": 1,
"title": "APOE Proteolytic Cleavage Suppression and Toxic N-terminal Fragment Reduction",
"mechanism": "R136S stabilizes native ...
Price History Overlay
Knowledge Graph Comparison
Complement C1QA Inhibition Synergizes wi
22 edges
Top Node Types gene 8
protein 5
mechanism 3
hypothesis 2
biomarker 2
Top Relations causes 4
enhances 2
associated_with 2
co_associated_with 2
modulates 2
TREM2 Activation as an Amplification Nod
22 edges
Top Node Types gene 8
protein 5
mechanism 3
hypothesis 2
biomarker 2
Top Relations causes 4
enhances 2
associated_with 2
co_associated_with 2
modulates 2